HERBAL COMMUNITY: Another consideration about Pharmacognosy
Pharmaceutics and Pharmacology Research · 2020
DOI: 10.31579/2693-7247/009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics and Pharmacology Research, 2020. Verfasst von Shah Murad und 5 weiteren Autor:innen.
Abstract (Originalsprache)
The metabolic disorders are main and increasing public-health and clinical challenge worldwide because of urbanization, excessive energy intake, increasing obesity, and sedentary life styles. According to International Diabetes Federation (IFD) diabetes is one of the major metabolic disorders and a dangerous risk factor for heart problems. Twenty five percent of the world’s adults have metabolic disorders. Recently in year 2013 the American Heart Association also reported that adults have abnormal serum lipid profile. Allopathic drugs used as hypolipidemic agents have number of unwanted effects. Herbal therapy for Hyperlipidemia is getting attention due to their less frequent side effects. In this study we have compared hypolipidemic effects of Fenofibrate 40 mg with Nigella sativa. Seventy five hyperlipidemic patients from National Hospital Lahore were enrolled for study. Consent was taken from all enrolled participants and were divided in three equal numbers ie; twenty five in each group. Group 1 was on Nigella sativa, group 2 was on Gemfibrozil and third group was on placebo therapy. They were advised to take drugs for two months. After completion of study pretreatment and post treatment values of LDL cholesterol were analyzed statistically. In 25 patients who were on Nigella sativa, their LDL cholesterol decreased from 191.14±3.45 to 159.40±2.98 mg/dl. 31.7 mg/dl LDL reduction was observed when compared with placebo group. In 25 patients who were on Fenofibrate 40 mg, their LDL cholesterol decreased from 197.77±3.91 mg/dl to 159.62±2.20 mg/dl. LDL reduction in this group was 38.2 mg/dl. These changes are highly significant with p-values of
Zitieren
APA
Murad, S., Rafique, S., Umar, A., Mahar, M. R., Awan, M. H., & Sangi, S. (2020). HERBAL COMMUNITY: Another consideration about Pharmacognosy. Pharmaceutics and Pharmacology Research. https://doi.org/10.31579/2693-7247/009
Vancouver
Murad S, Rafique S, Umar A, Mahar MR, Awan MH, Sangi S. HERBAL COMMUNITY: Another consideration about Pharmacognosy. Pharmaceutics and Pharmacology Research. 2020. doi:10.31579/2693-7247/009
BibTeX
@article{Murad2020,
author = {Murad, Shah and Rafique, Saima and Umar, Abrar and Mahar, Manal Raouf and Awan, M Hyder and Sangi, Sibghatullah},
title = {HERBAL COMMUNITY: Another consideration about Pharmacognosy},
journal = {Pharmaceutics and Pharmacology Research},
year = {2020},
doi = {10.31579/2693-7247/009}
}
EUVIMED